Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Income from Continuing Operations: 2016-2021

Historic Income from Continuing Operations for ENDRA Life Sciences (NDRA) over the last 6 years, with Dec 2021 value amounting to -$3.1 million.

  • ENDRA Life Sciences' Income from Continuing Operations fell 37.94% to -$3.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$11.2 million, marking a year-over-year increase of 4.22%. This contributed to the annual value of -$11.5 million for FY2024, which is 14.39% down from last year.
  • According to the latest figures from Q4 2021, ENDRA Life Sciences' Income from Continuing Operations is -$3.1 million, which was down 16.79% from -$2.7 million recorded in Q3 2021.
  • ENDRA Life Sciences' Income from Continuing Operations' 5-year high stood at -$741,623 during Q1 2017, with a 5-year trough of -$4.8 million in Q4 2019.
  • Moreover, its 3-year median value for Income from Continuing Operations was -$3.0 million (2020), whereas its average is -$3.0 million.
  • Per our database at Business Quant, ENDRA Life Sciences' Income from Continuing Operations tumbled by 280.96% in 2018 and then skyrocketed by 53.20% in 2020.
  • Over the past 5 years, ENDRA Life Sciences' Income from Continuing Operations (Quarterly) stood at -$2.3 million in 2017, then fell by 3.09% to -$2.4 million in 2018, then tumbled by 103.30% to -$4.8 million in 2019, then surged by 53.20% to -$2.3 million in 2020, then slumped by 37.94% to -$3.1 million in 2021.
  • Its Income from Continuing Operations was -$3.1 million in Q4 2021, compared to -$2.7 million in Q3 2021 and -$3.2 million in Q2 2021.